Top Companies in Middle East Pen Needles Market with Market Size | Suppliers 2025

Top Companies in Middle East Pen Needles Market with Market Size

The Middle East pen needles market is expected to witness significant growth between 2024 and 2030. The increasing prevalence of diabetes, rising healthcare expenditure, and technological advancements are some of the key factors driving this growth. Moreover, the growing awareness about self-administration of insulin among patients with diabetes is also contributing to the demand for pen needles in the region. As a result, many leading companies have entered the Middle East pen needles market to cater to this growing demand.

As the Middle East pen needles market continues to grow in the coming years, it is expected that several key companies will play a significant role in shaping and driving this growth. These companies have established themselves as leaders in the industry and are continuously innovating to meet the evolving needs of patients and healthcare providers. Through their extensive research and development efforts, these companies have been able to introduce advanced pen needle designs that offer better functionality, convenience, and safety for users. They also focus on developing products that cater to specific patient populations such as children or those with visual impairments.

In addition to their product offerings, these market leaders also contribute significantly to the overall expansion of the market through their strong distribution networks and strategic partnerships. They work closely with healthcare providers and organizations to increase awareness about the benefits of using pen needles and to promote their products. Furthermore, these companies are constantly investing in expanding their production capabilities to meet the growing demand for pen needles in the Middle East region. This not only helps them maintain a strong market share but also supports the overall growth of the market by ensuring an adequate supply of high-quality products. According to 6Wresearch, Middle East Pen Needles market size is projected to grow at a CAGR of 14.6% during 2025-2031.

List of Leading Companies in the Middle East Pen Needles Market with Market Size

1. BD (Becton Dickinson)

BD, also known as Becton Dickinson, is a global leader in medical technology. The company specializes in the development and manufacturing of medical devices, laboratory equipment, and diagnostic solutions. BD's range of pen needles includes the BD Ultra-Fine Nano Pen Needles, designed for comfortable insulin delivery. The company's innovation in diabetes care ensures high-quality and reliable solutions for patients worldwide.

2. Novo Nordisk A/S

Novo Nordisk is a multinational healthcare company focused on diabetes care, obesity, and other serious chronic diseases. It is one of the world's leading manufacturers of insulin and insulin delivery systems. The company produces high-quality pen needles under the brand NovoFine, which are designed for smooth and painless insulin injections. Novo Nordisk is known for its commitment to patient care, innovation, and research in diabetes management.

3. Ypsomed AG

Ypsomed is a Swiss medical technology company specializing in self-injection devices for diabetes and other medical conditions. The company manufactures high-precision pen needles under the brand Clickfine, which are designed to offer superior comfort and minimal pain during insulin administration. Ypsomed's products are widely used by healthcare professionals and patients seeking high-quality diabetes management solutions.

4. Sanofi S.A.

Sanofi is a leading pharmaceutical company with a strong presence in diabetes care. The company offers a variety of insulin pens and pen needles, including OptiClik, which is designed for easy use and compatibility with multiple insulin pen devices. Sanofi is dedicated to improving the quality of life for diabetes patients through innovative treatments and advanced drug delivery systems.

5. Owen Mumford Ltd.

Owen Mumford is a medical device manufacturer specializing in self-injection technology. The company produces Unifine Pentips, a range of high-quality pen needles that feature advanced technology for improved comfort and precise insulin delivery. Owen Mumford focuses on enhancing patient experiences by providing reliable and user-friendly injection devices.

6. NovoPen Echo - AstraZeneca PLC

AstraZeneca is a global pharmaceutical company engaged in the research, development, and manufacturing of innovative healthcare solutions. Under its NovoPen Echo brand, AstraZeneca provides high-quality pen needles such as NovoFine Plus, which are known for their precision and user-friendly design. The company’s diabetes care solutions are widely recognized for their efficiency in improving patient adherence to insulin therapy.

7. Terumo Medical Corporation

Terumo Medical Corporation is a Japanese medical device company that develops and manufactures high-quality injection systems. Its pen needle brand, Unifine Pentips Plus, features ultra-thin needle technology to ensure accurate and comfortable insulin administration. Terumo focuses on enhancing patient safety and ease of use through its advanced medical innovations.

8. Eli Lilly and Company

Eli Lilly is a global pharmaceutical leader known for its research and development of innovative diabetes care solutions. The company manufactures HumaPen, a line of insulin delivery devices that offer superior quality and compatibility with various insulin cartridges. Eli Lilly's contributions to diabetes management have helped millions of patients worldwide achieve better health outcomes.

9. Owen Mumford Ltd. (Repeated)

Owen Mumford is a pioneer in self-injection technology, offering a wide range of pen needles under the Unifine Pentips Plus brand. These needles are designed to enhance patient comfort and reduce injection pain, making diabetes management easier. The company’s commitment to innovation has made it a trusted name in the medical device industry.

10. GlaxoSmithKline Plc

GlaxoSmithKline (GSK) is a global pharmaceutical company with a broad portfolio of healthcare products, including diabetes care solutions. The company’s A-D Pen Needles are designed to provide precision, comfort, and ease of use for insulin-dependent patients. GSK’s long-standing expertise in pharmaceutical innovation has positioned it as a key player in the global healthcare industry.

Frequently Asked Questions About the Market Study (FAQs):